However, although KCNK1 is clearly not itself a candidate gene for psychosis in clinical populations, we leave open the possibility that it is a route by which biochemical changes associated with psychosis can lead to alterations in ocular tracking—for example, via activation of cannabinoid receptor 1 (see above). Here, CNR1 is linked to psychotic disorder.